 |
02.08.12 - Download PDF |
| |
Cytomedix Expands Commitment to Regenerative Medicine With Acquisition of Aldagen
|
|
01.26.12 - Download PDF |
| |
Aldagen Presents Data Describing Cell Therapy Products' Mechanism for Homing to Ischemic Injury
|
|
11.16.11 - Download PDF |
| |
Aldagen Announces Publication of Mechanism of Action Data For its Cardiovascular Cell Therapy Products
|
|
05.19.11 - Download PDF |
| |
Aldagen Announces Publication of Phase 1/2 Results for ALD-301, a Stem Cell Therapy in Development for Critical Limb Ischemia
|
|
05.28.11 - Download PDF |
| |
Aldagen Announces First Subject Enrolled and Clears Initial Safety Assessment in Phase 2 Stem Cell Study for Ischemic Stroke
|
|
05.19.11 - Download PDF |
| |
Aldagen Announces Publication of Phase 1/2 Results for ALD-301, a Stem Cell Therapy in Development for Critical Limb Ischemia
|
|
01.05.11 - Download PDF |
| |
Aldagen Announces FDA Clearance of IND to begin Phase 2 Study in Ischemic Stroke with Regenerative Cell Therapy
|
|
10.21.10 - Download PDF |
| |
Aldagen Announces Edward L. Field Appointed Vice Chairman of the Alliance for Regenerative Medicine
|
|
10.15.10 - Download PDF |
| |
Aldagen Announces Appointment of Lyle A. Hohnke, Ph.D. as Chief Executive Officer
|
|
02.23.10 - Download PDF |
| |
Aldagen Announces Strategic Management Changes
|
|
12.08.09 - Download PDF |
| |
Aldagen Announces Data Presented at American Society of Hematology Annual Meeting
|
